Cartesian Therapeutics, Inc. (RNAC)
10.17
+0.13
(+1.29%)
USD |
NASDAQ |
Aug 24, 16:00
10.17
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics Price : 10.17 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 10.35 | 10.69 | 10.00 | 10.04 | 163914.0 |
| Aug 20, 2026 | 10.34 | 10.43 | 9.86 | 10.23 | 134750.0 |
| Aug 19, 2026 | 9.50 | 10.87 | 9.326 | 10.49 | 482468.0 |
| Aug 18, 2026 | 9.06 | 9.612 | 9.00 | 9.20 | 138352.0 |
| Aug 17, 2026 | 8.97 | 9.53 | 8.745 | 9.18 | 108703.0 |
| Aug 14, 2026 | 8.77 | 8.96 | 8.504 | 8.84 | 86399.00 |
| Aug 13, 2026 | 8.76 | 8.89 | 8.70 | 8.72 | 57214.00 |
| Aug 12, 2026 | 8.59 | 8.86 | 8.47 | 8.675 | 74750.00 |
| Aug 11, 2026 | 8.82 | 8.82 | 8.43 | 8.585 | 74762.00 |
| Aug 10, 2026 | 8.79 | 8.885 | 8.64 | 8.76 | 55864.00 |
| Aug 07, 2026 | 8.88 | 8.95 | 8.615 | 8.85 | 84114.00 |
| Aug 06, 2026 | 8.48 | 8.87 | 8.446 | 8.76 | 105581.0 |
| Aug 05, 2026 | 8.15 | 8.50 | 8.10 | 8.35 | 113230.0 |
| Aug 04, 2026 | 7.93 | 8.61 | 7.77 | 8.06 | 297963.0 |
| Aug 03, 2026 | 7.89 | 7.93 | 7.675 | 7.87 | 111947.0 |
| Jul 31, 2026 | 7.77 | 7.80 | 7.31 | 7.80 | 140249.0 |
| Jul 30, 2026 | 7.42 | 7.74 | 7.36 | 7.73 | 98714.00 |
| Jul 29, 2026 | 7.68 | 7.91 | 7.27 | 7.42 | 168818.0 |
| Jul 28, 2026 | 7.84 | 7.84 | 7.42 | 7.65 | 106229.0 |
| Jul 27, 2026 | 7.99 | 8.35 | 7.78 | 7.79 | 79053.00 |
| Jul 24, 2026 | 7.94 | 8.030 | 7.66 | 7.88 | 143286.0 |
| Jul 23, 2026 | 7.99 | 8.26 | 7.60 | 7.92 | 140708.0 |
| Jul 22, 2026 | 8.07 | 8.312 | 7.98 | 8.13 | 86543.00 |
| Jul 21, 2026 | 8.07 | 8.29 | 7.905 | 8.13 | 151831.0 |
| Jul 20, 2026 | 8.33 | 8.485 | 8.03 | 8.18 | 114126.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Allogene Therapeutics, Inc. | 2.035 |
| Beam Therapeutics, Inc. | 28.34 |
| C4 Therapeutics, Inc. | 4.11 |
| Kyverna Therapeutics, Inc. | 8.23 |
| Arrowhead Pharmaceuticals, Inc. | 86.74 |
Price Related Metrics
| PS Ratio | 187.17 |
| PEG Ratio | -0.0021 |
| Earnings Yield | -58.40% |
| Market Cap | 305.49M |
| PEGY Ratio | -0.0021 |